EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer

Fabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, Dhanya R Panickar, Lester J Lambert iD, Maria Celeridad, Jiaqian Wu iD, Laurent De Backer, Preeti Chandrachud, Allison S Limpert, Mitchell Vamos, Apirat Chaikuad iD und 9 weitere

ACS Chemical Biology · 20.03.2026 · 21 (3) · 469-489

DOI: 10.1021/acschembio.5c00711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 12.02.2026. Verfasst von Fabiana Izidro A L Layng und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Therapeutics Discovery, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, Unit…. Hauptthemen laut MEDLINE: Autophagy, Carcinoma, Non-Small-Cell Lung, Autophagy-Related Protein-1 Homolog, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: NCI NIH HHS, Janssen Research and Development, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyCarcinoma, Non-Small-Cell LungAutophagy-Related Protein-1 HomologProtein Kinase InhibitorsLung NeoplasmsProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsAntineoplastic AgentsHistocompatibility Antigens Class IHumansUp-RegulationCell Line, TumorA549 Cells

Substanzen

Autophagy-Related Protein-1 HomologProtein Kinase InhibitorsULK1 protein, humanProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsUlk2 protein, humanAntineoplastic AgentsHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Center for Therapeutics Discovery, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States.
  • Structural Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Goethe-University Frankfurt, Frankfurt 60438, Germany.
  • Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, Frankfurt 60438, Germany.
  • Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, United States.

ORCID-Profile: Lester J Lambert, Jiaqian Wu, Apirat Chaikuad, Stefan Knapp, Guy S Salvesen, Nicholas D P Cosford

Förderung

  • NCI NIH HHS
  • Janssen Research and Development
  • National Cancer Institute
  • Bayer
  • Genentech
  • Takeda Pharmaceutical Company
  • Pfizer
  • Bristol-Myers Squibb

Zitieren

APA

Layng, F. I. A. L., Ren, H., Bakas, N. A., Panickar, D. R., Lambert, L. J., Celeridad, M., Wu, J., De Backer, L., Chandrachud, P., Limpert, A. S., Vamos, M., Chaikuad, A., Verdugo, B. B., Hagan, P. M., Brun, S. N., Tautz, L., Knapp, S., Shaw, R. J., Salvesen, G. S., …, & Cosford, N. D. P. (2026). Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer. ACS Chemical Biology, 21(3), 469-489. https://doi.org/10.1021/acschembio.5c00711

Vancouver

Layng FIAL, Ren H, Bakas NA, Panickar DR, Lambert LJ, Celeridad M, et al. Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer. ACS Chemical Biology. 2026;21(3):469-489. doi:10.1021/acschembio.5c00711

BibTeX
@article{Layng2026,
  author = {Layng, Fabiana Izidro A L and Ren, Huiyu and Bakas, Nicole A and Panickar, Dhanya R and Lambert, Lester J and Celeridad, Maria and Wu, Jiaqian and De Backer, Laurent and Chandrachud, Preeti and Limpert, Allison S and Vamos, Mitchell and Chaikuad, Apirat and Verdugo, Betsaida B and Hagan, Patrick M and Brun, Sonja N and Tautz, Lutz and Knapp, Stefan and Shaw, Reuben J and Salvesen, Guy S and Sheffler, Douglas J and Cosford, Nicholas D P},
  title = {Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer},
  journal = {ACS Chemical Biology},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {469--489},
  doi = {10.1021/acschembio.5c00711}
}
Kostenlos starten →